According to previous reports, NGS detection revealed that TP53, SRSF2, and TET2 mutations were poor prognostic factors; especially SRSF2 mutations, which could accelerate the transformation of MPN to AML.37 This evidence concerns the gene TP53 and myeloproliferative neoplasm.